NATCO gets US FDA approval for Pomalidomide capsules
It is indicated for the treatment of multiple myeloma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Natco Pharma
Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug
The terms of the agreement are confidential as per the agreement
NATCO supports Columbia University’s clinical trial of chloroquine phosphate
Researchers at Columbia University are conducting this critical study to assess CQ
as prophylaxis against COVID-19 in healthcare…
Natco Pharma gets USFDA approval for Visakhapatnam facility
The company did not disclose the product approved by the USFDA to be produced from the facility
Dapnat launch to boost Natco’s presence in India’s diabetes market but concerted efforts required,…
Natco is a new player within the cardiovascular and diabetes therapeutic space, launching its Cardiology and Diabetic (CnD)…
Natco Pharma gets EIR from USFDA for Telangana facility
USFDA had conducted pre-approval inspection at Natco’s facility in Kothur village from March 2-6, 2020
Natco Pharma Q3 net profit declines 34 per cent to Rs 104.4 crore
Consolidated total income stood at Rs 513 crore for the quarter under consideration
Natco Pharma reported a 34.46 per cent drop…
Facing headwinds in US, Natco Pharma looks to scale up business in China
In the near term, the pharmaceutical company would continue to be driven by markets like India, Brazil and Canada
US FDA issues six observations to Natco Pharma’s API facility near Hyderabad
The company believes that none of observations are related to data integrity and that all the observations can be addressed within…
Natco Pharma receives EIR from US FDA
The EIR was issued for its Kothur facility in Telangana